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Introduction. Ischemia/Reperfusion (I/R) is a primary cause of myocardial injury after acute myocardial infarction resulting in the
release of damage-associated molecular patterns (DAMPs), which can induce a sterile inflammatory response in the myocardial
penumbra. Targeted temperature management (TTM) after I/R has been established for neuroprotection, but the
cardioprotective effect remains to be elucidated. Therefore, we investigated the effect of TTM on cell viability, immune response,
and DAMP release during oxygen-glucose deprivation/reperfusion (OGD/R) in murine primary cardiomyocytes. Methods.
Primary cardiomyocytes from P1-3 mice were exposed to 2, 4, or 6 hours OGD (0.2% oxygen in medium without glucose and
serum) followed by 6, 12, or 24 hours simulated reperfusion (21% oxygen in complete medium). TTM at 33.5°C was initiated
intra-OGD, and a control group was maintained at 37°C normoxia. Necrosis was assessed by lactate dehydrogenase (LDH)
release and apoptosis by caspase-3 activation. OGD-induced DAMP secretions were assessed by Western blotting. Inducible
nitric oxide synthase (iNOS), cytokines, and antiapoptotic RBM3 and CIRBP gene expressions were measured by quantitative
polymerase chain reaction. Results. Increasing duration of OGD resulted in a transition from apoptotic programmed cell death
to necrosis, as observed by decreasing caspase-3 cleavage and increasing LDH release. DAMP release and iNOS expression
correlated with increasing necrosis and were effectively attenuated by TTM initiated during OGD. Moreover, TTM induced
expression of antiapoptotic RBM3 and CIRBP. Conclusion. TTM protects the myocardium by attenuating cardiomyocyte
necrosis induced by OGD and caspase-3 activation, possibly via induction of antiapoptotic RBM3 and CIRBP expressions,
during reperfusion. OGD induces increased Hsp70 and CIRBP releases, but HMGB-1 is the dominant mediator of inflammation
secreted by cardiomyocytes after prolonged exposure. TTM has the potential to attenuate DAMP release.
1. Introduction
Acute myocardial infarction (AMI) is a leading cause of
death worldwide. Myocardial ischemia followed by therapeu-
tic reperfusion can induce a sterile inflammatory response by
enhancing the production of cytokines and reactive oxygen
species (ROS), which usually occurs in the early reperfusion
phase. ROS can cause direct damage to cell structures and
genomic DNA, as well as recruit neutrophil granulocytes,
monocytes, and macrophages to the infarct area by chemo-
taxis and initiate an inflammatory response [1]. Typical
promoters of inflammation are the cytokines interleukin-6
(IL-6), interleukin-1β (IL-1β), and tumor necrosis factor-α
(TNF-α), which are secreted by the damaged cells them-
selves, as well as by the recruited immunocompetent cells.
This inflammatory response can also be referred to as sterile
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Other contributing factors to inflammation are damage-
associated molecular patterns (DAMPs), which are released
or secreted into the extracellular matrix by ischemia/reperfu-
sion- (I/R-) induced injured cells. These DAMPs bind to pat-
tern recognition receptors (PRR), including toll-like
receptors (TLR), of neighboring or recruited immunocompe-
tent cells. The subsequent induction of the transcription fac-
tor, nuclear factor kappa-light-chain-enhancer of activated
B-cells (NF-κB), further stimulates the synthesis of cytokines,
thereby maintaining or even exacerbating the inflammatory
response [2]. Molecules that are referred to as DAMPs can
be proteins or ADP/ATP.
Cold-inducible RNA-binding protein (CIRBP) is a
nuclear protein, which when localized intracellularly pro-
vides cytoprotection by suppressing apoptosis and preserving
RNA and DNA stability [3, 4]. Stimuli that lead to the upreg-
ulation of its expression include hypoxia and hypothermia,
thus categorizing CIRBP as a so-called cold-shock protein
[3, 5]. During hypothermia, CIRBP binds to different tran-
scripts to stabilise and accelerate their translation [6]. These
cytoprotective effects have already been confirmed in vivo
by Wang et al., who showed that cooling rats to a tempera-
ture of 31 ± 0:5°C after a traumatic brain injury leads to the
suppression of apoptosis in certain brain regions, which cor-
related with increased CIRBP mRNA and protein expres-
sions in the same regions and was abolished by silencing
CIRBP [7]. However, in the case of cellular stress, CIRBP is
methylated and translocates from the nucleus to the cytosol
where it either binds to the mRNA of stress-induced mole-
cules or is preserved in stress granules [6]. Furthermore, cel-
lular damage can lead to the release of CIRBP to the
extracellular matrix where it acts as a DAMP and contributes
to the inflammatory response by stimulating the secretion of
TNF-α and high-mobility group box-1 (HMGB-1) [6]. A
clinical study by Zhou et al. demonstrated that plasma levels
of CIRBP in septic patients were significantly lower in surviv-
ing patients than in those who died of sepsis, and high plasma
levels of CIRBP correlated with a poorer outcome as assessed
by Acute Physiology And Chronic Health Evaluation II
(APACHE II) and sequential organ failure assessment
(SOFA) scores [8]. These findings further emphasize the
increasingly important role of extracellular CIRBP in the
clinical setting.
RNA-binding motif protein 3 (RBM3) is another cold-
shock protein with antiapoptotic and cytoprotective proper-
ties that is closely related to CIRBP. In contrast to CIRBP,
RBM3 has so far not been described as a DAMP [3]. To date,
both cold-shock proteins have mostly been observed in neu-
ronal cells and are associated with hypothermia-induced
neuroprotection.
Therapeutic hypothermia (TH), also referred to as tar-
geted temperature management (TTM), has been established
for neuroprotection and is a promising cardioprotective ther-
apeutic strategy, as suggested by many in vitro and in vivo
studies. However, the effect of TTM on the mechanisms
and kinetics of the sterile inflammatory response after AMI
remains to be elucidated. Therefore, we investigated the effect
of intraischemic moderate TH (33.5°C) on murine primary
cardiomyocytes viability after exposure to oxygen-glucose
deprivation (OGD) and reperfusion (OGD/R). We also
investigated the expression and release of DAMPs induced
by exposure to OGD, as well as the sterile inflammatory
response. Moreover, we also investigated the effect of TTM
on RBM3 and CIRBP expressions in OGD/R-injured
cardiomyocytes.
2. Materials and Methods
2.1. Animals and Preparation of Primary Cultures. All animal
experiments were approved and performed in accordance
with the guidelines of the Charité – Universitätsmedizin Ber-
lin, Germany. Animals were housed in a conventional animal
facility at the Center for Anatomy, Charité –Universitätsme-
dizin Berlin, Germany.
2.2. Preparation of Murine Primary Cardiomyocytes. Murine
primary cardiomyocytes were isolated from P1-3 C57/BL6N
mice using the Pierce™ Primary Cardiomyocyte Isolation Kit
(Thermo Fisher) according to the manufacturer’s recom-
mended protocol. Briefly, dissected hearts were cut into 1-
3mm2 pieces in Hanks’ Balanced Salt Solution (HBSS),
washed, and digested with two tissue-specific dissociation
enzymes (papain and thermolysin) for 30 minutes at 37°C. Iso-
lated cells were then resuspended in Dulbecco’s modified eagle
medium (DMEM) formulated for primary cell culture (Pierce
Primary Cardiomyocyte Isolation Kit) supplemented with
10% fetal bovine serum (FBS, Merck Millipore) and 0.2% pri-
mocin (Invivogen). For each experimental group, 3 × 106 cells
were plated out in 40mm diameter Petri dishes (TPP) and cul-
tivated for 24 hours at 37°C in a humidified incubator with 21%
O2 and 5% CO2. Afterward, the medium was changed to a
complete medium containing a growth supplement (1 : 1000,
Pierce Primary Cardiomyocyte Isolation Kit) to promote the
isolation, enrichment, and growth of functional cardiomyo-
cytes. Cells were further cultivated for an additional 6 days with
a medium change every subsequent two days.
2.3. Oxygen-Glucose Deprivation/Reperfusion (OGD/R).
Ischemia-reperfusion injury was simulated in vitro by expo-
sure to OGD/R, as previously established in our laboratory
[9]. Briefly, primary cardiomyocytes were deprived of oxygen
and glucose for up to 6 hours in glucose/serum free DMEM
(Thermo Fisher) at 0.2% O2 and 5% CO2 in a humidified
CO2 incubator (Binder) [10]. Control groups were kept at
normoxia (21% O2) in complete medium (DMEM contain-
ing glucose and 10% FBS (Merck Millipore)). After 2-6 hours
of OGD, reperfusion was simulated by restoration of nutri-
ents and oxygen in complete medium at 21% O2. All experi-
mental media were supplemented with 0.2% Primocin
(InvivoGen) and 2mM L-glutamine (Merck Millipore).
2.4. Targeted Temperature Management (TTM). We previ-
ously established a time-temperature protocol for intrais-
chemic cooling (33.5°C) of the cardiomyocytes (see
Figure 1) [10, 11]. Briefly, normothermic OGD/R-injured
groups were maintained at 37°C for the duration of the
experiment, while TTM groups were cooled to 33.5°C after
1-hour exposure to OGD and maintained during simulated
reperfusion for 24 hours. Samples for determining the
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underlying cell death mechanisms were analyzed directly
after OGD (2-6 h) and 6 hours reperfusion (8-12 h), respec-
tively. In order to thoroughly investigate the effect of OGD/R
and TTM on the cardiomyocytes, samples were also analyzed
after 6 hours OGD followed by 12 and 24 hours reperfusion.
2.5. Assessment of Lactate Dehydrogenase (LDH) Release.
Necrotic cell death was quantified by LDH release into the
cultured supernatant using a colorimetric Cytotoxicity
Detection Kit (Roche Diagnostics) according to the manufac-
turer’s instructions. After each experimental time point, cul-
tured supernatants were collected, centrifuged, and mixed
with reagents (1 : 1) in a 96-well plate. Extinction was mea-
sured at 570nmminus 630nm using a microtiter plate reader
(Multiskan Reader Ascent, Thermo Fisher). LDH release is
expressed as percent cytotoxicity relative to total LDH con-
tent, as determined from lysed normoxic control cells using
a freeze/thaw method at -80°C, and normothermic normoxia
untreated group as baseline control for spontaneous LDH
release.
2.6. Intracellular and Extracellular Proteins Isolation and
Western Blot Analysis. After 2, 4, and 6 hours of OGD, intra-
cellular and extracellular proteins were isolated for Western
blot analysis. Briefly, intracellular proteins were isolated from
attached cells that were washed with ice-cold PBS, dislodged
using a cell scraper, and lysed using a modified RIPA buffer
(50mM Tris–HCl at pH7.5, 150mM sodium chloride, 1%
Triton X-100, 0.1% sodium dodecylsulfate, 0.5% Na-deoxy-
cholate, 2mM ethylenediaminetetraacetic acid, 1mM phe-
nylmethylsulfonyl fluoride, sodium fluoride, and protease
inhibitor cocktail 3, all from Sigma-Aldrich) and quantified
using a BCA Protein Assay Kit (Pierce Biotechnology). Extra-
cellular proteins were isolated using a trichloroacetic acid
precipitation method. Briefly, 1mL cell cultured superna-


















Figure 1: Experimental time-temperature protocol. Normothermic OGD/R-induced injury groups were maintained at 37°C for the duration
of the experiment, while TTM-treated groups were cooled to 33.5°C after 1 hour exposure to OGD and maintained during the simulated
reperfusion phase. Experimental samples were analyzed (a) directly after exposure to increasing duration of OGD (2-6 h) and 6 hours of
simulated reperfusion (8-12 h after experimental start, respectively) or (b) directly after exposure to 6 hours OGD and 12 or 24 hours of
simulated reperfusion (18 and 30 h after experimental start, respectively).
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(VWR) for 30 minutes on ice and centrifuged at 16,000xg for
20 minutes to precipitate proteins. The proteins were washed
with ice-cold acetone, dried, and dissolved in 25μL modified
RIPA buffer. Subsequently, 30μg intracellular and total
extracellular isolated proteins were incubated with Pierce
Lane Marker Reducing Sample Buffer (Thermo Scientific)
at 95°C for 5 minutes, subjected to 15% SDS polyacrylamide
gel electrophoresis, and transferred to a polyvinylidene fluo-
ride membrane (PALL Life Sciences) overnight at 30V using
a tank blot procedure (Bio-Rad). The membrane was blocked
for 1 hour at room temperature using 5% bovine serum albu-
min (Carl Roth) for Hsp70 and HMGB-1 or 5% dry milk
(AppliChem) for CIRBP in TBS + 0:1%Tween 20. Primary
antibodies against Hsp70 (1 : 1000, Cell Signaling #4872),
HMGB-1 (1 : 1000, Chondrex, #7028) and CIRBP (1 : 500,
Proteintech (10209-2-AP)) were diluted in respective block-
ing solution and incubated overnight at 4°C, and HRP-
conjugated secondary antibodies (anti-rabbit IgG
(1 : 20,000), Dianova) were incubated for 1 hour at room
temperature. Protein expression was visualized using Dura
Super Signal West (Thermo Scientific) according to the man-
ufacturer’s instructions, and subsequent densitometry analy-
sis was performed using the ChemiDoc™ Imaging Systems
and Image Lab (Bio-Rad).
2.7. RNA Isolation and RT-qPCR Analysis. Total RNA from
murine primary cardiomyocytes was isolated using the
GenUp™ Total RNA Kit (Biotechrabbit) according to the
manufacturer’s recommended protocol. RNA concentration
and purity were determined by spectrophotometric measure-
ments at 260 and 280 nm using a Nanodrop 2000 (Nano-
drop) and 1% agarose gel electrophoresis, respectively.
CDNA was transcribed from 1000ng total RNA using the
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems) and PTC200 Thermal Cycler (MJ Research).
Expression of target genes and the endogenous control,
gylcerinaldehyde-3-phosphate dehydrogenase (GAPDH),
was assessed by real-time qPCR using the TaqMan® Gene
Expression Assays (see Table 1) and StepOnePlus™ Real-
Time PCR System (Applied Biosystems) according to manu-
facturer’s recommendations. Reactions with no reverse tran-
scripts and templates were included as negative controls.
Relative quantification of target gene expression was normal-
ized to the housekeeping gene using the 2 − ΔΔctmethod and
illustrated as fold change [12].
2.8. Statistical Analysis. Data were analyzed and graphed
using GraphPad Prism 5 (GraphPad Software). Results were
expressed as means ± standard deviations (SD). Experiments
were independently repeated at least three times. One-way
ANOVA followed by Tukey’s posttest was used for multiple
group comparisons and p < 0:05 was considered statistically
significant (∗, group comparison; #, compared to normoxia
control).
3. Results
3.1. The Effect of TTM on OGD/R-Induced Necrosis and
Apoptosis in Murine Primary Cardiomyocytes. Increasing
duration of exposure to OGD resulted in increased cytotoxic-
ity in the murine primary cardiomyocytes, as assessed by the
increased release of LDH into the cultured medium (see
Figure 2(a)). Maximum cytotoxicity (29.6%) was observed
in the uncooled OGD group after 6 hours exposure and
was significantly higher relative to 4 hours (16.4%) and 2
hours (4.6%) exposure to OGD. Hypoxia has been shown
to induce oxidative stress leading to apoptosis in the myocar-
dium [13]. Apoptotic programmed cell death as assessed by
cleavage of caspase-3 via Western blotting and was observed
in the reperfusion phase after exposure to OGD (see
Figure 2(b)). Maximum cleavage of caspase-3 (1.7-fold
increase) was observed after exposure to OGD for 2 hours
followed by reperfusion for 6 hours and significantly
decreased with extended exposure to OGD (0.9-fold increase
for 4 hours and undetectable for 6 hours OGD), relative to
normoxic control. In general, we observed that increasing
duration of exposure to OGD resulted in a transition from
apoptotic to necrotic cardiomyocyte cell death. Moreover,
TTM significantly attenuated cardiomyocyte necrosis in the
6 hours OGD group (29.6 to 17.7%) and apoptosis in the 2
hours OGD followed by 6 hours reperfusion group (1.7- to
0.7-fold increase). Interestingly, exposure to 4 hours OGD
followed by 6 hours reperfusion at 37°C resulted in slightly
lower caspase-3 cleavage (0.9-fold increase), but cooling to
33.5°C resulted in significantly reduced cleavage of caspase-
3 (0.5-fold increase) relative to homeostasis level observed
in the normoxia control.
3.2. The Effect of TTM on OGD/R-Induced Innate Immune
Response in Murine Primary Cardiomyocytes. Ischemia/re-
perfusion injury often results inflammation of the myocar-
dium that is primarily evidenced by an innate immune
response. Therefore, we investigated the effect of TTM on
various mediators of inflammation including the inducible
nitric oxide synthase (iNOS) and inflammatory cytokine
gene expressions in OGD/R-injured murine primary cardio-
myocytes. Prolonged exposure to OGD resulted in a signifi-
cant increase in iNOS expression (6 hours) (169-fold
increase) compared to normoxia control that was not atten-
uated by cooling (142.2-fold increase), but was significantly
lower at all investigated time points after reperfusion (see
Figures 3(a) and 3(b), respectively). IL-1β has been observed
to be markedly upregulated in the infarcted myocardium [14,
15]. We observed increasing IL-1β expression with increas-
ing duration of exposure to OGD, while expression was gen-
erally suppressed in the reperfusion phase (see Figures 3(c)
and 3(d), respectively). In contrast to IL-1β, increasing the
duration of OGD had no significant effect on IL-6 expression
(see Figure 3(e)). However, IL-6 gene expression tends to be
Table 1: TaqMan® Gene Expression Assays.
Gene Assay ID Gene Assay ID
IL-1β Mm00434228_m1 iNOS Mm00440502_m1
IL-6 Mm00446190_m1 TNF-α Mm00443260 g1
CIRBP Mm00483336_g1 RBM3 Mm01609819_g1
GAPDH Mm99999915_g1
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increased in the normothermic group during the reperfusion
phase and was potentially but not significantly attenuated by
cooling (see Figure 3(f)). Finally, TNF-α is another proin-
flammatory cytokine expressed in the myocardium after
acute myocardial ischemia infarction [15]. However, we did
not observed any significant changes in TNF-α expression
after OGD/R-induced injury in the primary cardiomyocytes
at both 37 and 33.5°C (see Figures 3(g) and 3(h), respec-
tively). TTM tends to induced TNF-α expression in both
the OGD and reperfusion phases, but did not reached
significancy.
3.3. The Effect of TTM on OGD-Induced DAMP Release from
Murine Primary Cardiomyocytes. Damage-associated molec-
ular patterns or DAMPs are constituents of dying cardio-
myocytes that are released from the damaged myocardium
and can induce a sterile inflammatory response following
myocardial infarction [16]. Therefore, we investigated the
effect of TTM and OGD/R on intracellular DAMP expres-
sion and extracellular release from murine primary cardio-
myocytes. Specifically, the intracellular protein expression
and release of HMGB-1, Hsp70, and CIRBP were investi-
gated. Increasing exposure to OGD (2-6 hours) had no sig-
nificant effect on intracellular HMGB-1, Hsp70, and CIRBP
protein expressions (see Figures 4(a), 4(c), and 4(e), respec-
tively). Cooling also had no observable effect on intracellular
HMGB-1 and CIRBP expressions during the OGD phase, but
significantly induced Hsp70 expression relative to normo-
thermic control after 2 hours OGD. Although no significant
changes in intracellular DAMP expressions were observed,
we did observe a significant increase in the release of
HMGB-1 when exposure to OGD was prolonged from 2
hours to 6 hours (see Figure 4(b)). We also observed increas-
ing but not significant release of Hsp70 and CIRBP into the
cultured supernatants with increasing duration of OGD
(see Figures 4(d) and 4(f), respectively). TTM-treated groups
had generally lower release of DAMPs in the OGD phase,
though not significant.
3.4. The Effect of TTM on OGD/R-Induced Expression of
RBM3 and CIRBP in Murine Primary Cardiomyocytes.
RBM3 and CIRBP belong to the family of cold-inducible
RNA-binding proteins that have been shown to have antia-
poptotic effects [4, 17]. Both RBM3 and CIRBP gene expres-
sions were significantly suppressed by exposure to OGD for 6
hours at 37°C, with no significant changes observable in the
reperfusion phase, relative to normoxic control (see
Figures 5(a) and 5(b), respectively). TTM significantly atten-
uated RBM3 and CIRBP suppressions in the OGD phase and
restored gene expression levels back to the normoxic control
levels. Moreover, TTM significantly induced both RBM3 and
CIRBP expressions in the reperfusion phase, and longer
exposure to cooling resulted in significantly increased expres-
sions of both RBM3 and CIRBP in a time-dependent manner
in the primary cardiomyocytes.
4. Discussion
Our study confirms the cardioprotective effect of targeted
temperature management during simulated ischemia/reper-
fusion-induced injury in murine primary cardiomyocytes.
Moderate cooling to 33.5°C initiated during the OGD phase
and maintained into the OGD/R phase successfully attenu-
ates OGD-induced necrotic cell death as well as OGD/R-
induced apoptotic programmed cell death. We also observed
a transition from prevailing necrotic cell death with increas-
ing duration of OGD to apoptotic programmed cell death































































Figure 2: Increasing duration of OGD exposure resulted in a transition from apoptotic to necrotic cell death in the murine primary
cardiomyocytes that could be attenuated by TTM. (a) OGD-induced toxicity as measured by LDH release at 2, 4, and 6 hours is presented
as % cytotoxicity relative to positive (100%) and normoxia (0%) controls. (b) Apoptotic programmed cell death was assessed by cleavage
of caspase-3 after exposure to 2, 4, or 6 hours OGD followed by 6 hours of reperfusion and is presented as x-fold change relative to
normoxia control at the respective experimental time points. Data from at least 3 independent experiments are shown as mean ± SD, and
statistical analysis was performed using one-way ANOVA with Tukey posttest; #p < 0:05 as compared to 37°C normoxia control group
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by reperfusion for 6 hours. This transition in cell death mech-
anism can be attributed to a decrease in intracellular ATP
content that has been observed during ischemia, as well as
energy-dependent crucial activation steps of apoptosis that
predominantly proceed after the restoration of energy during
the reperfusion phase [18]. Moreover, the intensity of the ini-
tial damage in the sense of prolonged exposure to OGD is
another crucial factor in determining the resulting cell death
mechanism, as previously demonstrated by Bonfoco et al., in
cortical neurons [19]. Therefore, the decrease in ATP con-
centrations due to increasing duration of OGD results in
compensatory mechanisms failure, cell rupture, and ulti-
mately necrosis, whereas short-term OGD-induced damage
leads to the induction of apoptosis in the following reperfu-
sion phase.
TTM protects cardiomyocytes from OGD/R-induced
injury by attenuating necrosis after prolonged exposure to
OGD, as demonstrated by a decreased LDH release into the
cultured supernatant. TTM also attenuated apoptosis in the
reperfusion phase after a shorter exposure to OGD, thus
increasing cell viability in general. The antiapoptotic effect
of cooling, as assessed by the attenuation of caspase-3 activa-
tion has so far been mostly observed in neurons [20–22], but
not extensively investigated in cardiac cells. Our experimen-
tal study shows that the antiapoptotic effect of TTM is also
implemented by the attenuation of caspase-3 activation in
primary murine cardiomyocytes. However, since caspase-3
is the common end line effector for both the intrinsic and
extrinsic apoptotic pathways, no conclusions can be drawn
about the origin of the initiating stimulus.
We also observed a significant increase in gene expres-
sion of the antiapoptotic cold-shock proteins, CIRBP and
RBM3, during reperfusion in the cooled experimental
groups. Even though no significant increases in the gene
expressions of RBM3 and CIRBP were observable during
OGD, cooling effectively preserved homeostasis gene expres-
sion levels comparable to the normoxic control group,
whereas CIRBP and RBM3 gene expressions were signifi-
cantly decreased in the uncooled OGD groups. To date, these
cold-shock proteins have been described to exert antiapopto-
tic effects in neuronal cells, and specifically, RBM3 has been
discussed as a potential therapeutic approach in neurodegen-
erative diseases due to its association with preserving neuro-
plasticity [23]. Even though the cytoprotective mechanisms
are not fully understood, in vitro studies suggest that
hypothermia-induced upregulation of RBM3 leads to the
suppression of poly(ADP-ribose) polymerase 1 (PARP)
cleavage, a crucial step in caspase-dependent apoptosis [17],
while CIRBP interferes with the mitochondrial apoptotic sig-
naling pathways [4]. A study conducted by Long et al. dem-
onstrated that overexpression of CIRBP further promotes
cell proliferation and reduces ROS production through the
inhibition of the NF-κB signaling pathway in H9C2 cardio-
myocytes subjected to simulated ischemia. CIRBP knock-
down, however, leads to opposite effects including
decreased cell viability and enhanced apoptosis [24]. This is
in accordance with our results that show antiapoptotic
RBM3 and CIRBP are not only expressed in neuronal cells
but also in cardiomyocytes, suggesting a crucial mechanism
in the cardioprotective effects induced by TTM. Our data
suggests that TTM not only increases cell viability by attenu-
ating necrosis during ischemia and apoptosis in the early
reperfusion phase by reducing caspase-3 activation but could
possibly have a sustained protective effect in the late reperfu-
sion phase by the upregulation of the antiapoptotic cold-
shock proteins. However, the exact regulatory mechanisms
exerted by RBM3 and CIRBP in primary cardiomyocytes
remain to be elucidated.
NO has both antioxidative and anti-inflammatory effects
under normoxic conditions [25], but it can also generate
reactive nitrogen species free radicals under hypoxia [26,
27]. In cardiomyocytes, endothelial NOS (eNOS) is constitu-
tive, and iNOS is mostly transcriptionally regulated and
































































Figure 3: RT-qPCR gene expression analysis of OGD/R-induced innate immune response of (a, b) iNOS inflammatory enzyme and
proinflammatory cytokines (c, d) IL-1β, (e, f) IL-6, and (g, h) TNF-α in murine cardiomyocytes after exposure to 2, 4, and 6 hours OGD
followed by 12 and 24 hours reperfusion (18 hours and 30 hours after experimental start, respectively) at 37°C and 33.5°C. Data from at
least 3 independent experiments are shown as mean ± SD. Statistical analysis was performed using one-way ANOVA with Tukey posttest;
#p < 0:05 as compared to 37°C normoxia control group and ∗p < 0:05 comparison between the two experimental groups were considered
significant.
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increases during the OGD phase and is significantly
increased in both the normothermic and hypothermic
groups after 6 hours exposure to OGD, which correlates with
the observed amount of necrotic cell death. No significant
increase in iNOS was observed after reperfusion. Moderate
TH tends to reduce the expression of iNOS in primary cardi-
omyocytes during OGD. Contrary to our observations in the
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Figure 4: Western blot analysis of intracellular expression and extracellular release of the following DAMPs: (a, b) HMGB-1, (c, d) Hsp70,
and (e, f) CIRBP after exposure to 2, 4, and 6 hours OGD at 37°C and 33.5°C, respectively. Data from at least 3 independent experiments are
shown asmean ± SD. Statistical analysis was performed using one-way ANOVAwith Tukey posttest; #p < 0:05 as compared to 37°C normoxia
control group and ∗p < 0:05 comparison between the two experimental groups were considered significant.
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NO and iNOS protein expression after acute ischemia in a rat
model of cerebral artery occlusion, as well as in a microglia
culture stimulated with lipopolysaccharides (LPS) and cooled
to 33°C [28]. The importance of iNOS in the context of I/R-
induced injury in the literature is still controversial [29], as
there are studies suggesting both damaging [30] and cardio-
protective effects [31] induced by iNOS gene expression.
Ultimately, the ratio between protective NO and reactive
nitrogen compounds that arise during NO degradation
seems to be decisive balance for either the protective or
harmful effect of iNOS [29] and warrants further investiga-
tion. Moreover, iNOS gene expression is dependent on NF-
κB activity and is involved in the innate immune response
to proinflammatory cytokines.
The inflammatory response occurring in the context of
AMI is another process that can be modulated by cooling.
It has been shown in vivo that moderate TH inhibits the acti-
vation of microglia and weakens the inflammatory response
by inhibiting the TLR-4 signaling pathway [32]. TLR-4 and
other pattern recognition receptors (PRR) lead to activation
of NF-κB, which enhances iNOS and cytokine production
and the inflammatory response and can therefore be attenu-
ated by cooling [33–35]. In this study, we investigated the
cytokine dynamics of proinflammatory IL-1β, IL-6, and
TNF-α during OGD and after reperfusion. In an in vivo rat
model, Shi et al. demonstrated the anti-inflammatory effect
of moderate TH (32°C) initiated 2 minutes after coronary
artery occlusion, as measured by significant reductions in
proinflammatory cytokines IL-6 and TNF-α expressions
[36]. In our experimental study, gene expression levels of
the investigated proinflammatory cytokines were not signifi-
cantly increased during OGD/R compared to normoxic levels
and also not significantly affected by TTM. These findings are
not generally conflicting with the observations by Shi et al., as
their in vivo rat model investigated the whole myocardium
and measured the increase in overall inflammatory response
from all cells involved [36]. However, cardiomyocytes
amount to only 30-35% of the entire myocardium [37]. Addi-
tionally, nuclear translocation of the transcription factor NF-
κB, which is responsible for cytokine induction, is mainly
observed in interstitial cells of the myocardium and not in
cardiomyocytes [38], thus correlating with the lack of immu-
noresponse observed in our experiments. Although primary
cardiomyocytes are essentially nonimmunocompetent cells,
they are generally perceptive to other detrimental stimuli
such as DAMPs. Mathur and colleagues have shown that
Hsp70, which has been previously described as a DAMP
and has also been investigated by our group, is able to bind
to the TLR-2 and cause contractile dysfunction in HL-1 car-
diomyocytes [39]. This shows that the lack of immune
response in the cardiomyocytes is not due to the absence of
PRR but is rather based on differing intracellular signaling
pathways. However, we have demonstrated that primary car-
diomyocytes can nevertheless contribute to the initiation of
the sterile inflammatory response through the release of
DAMPs, which can potentially be attenuated by cooling
(see Figure 6). This is in correlation with our previous obser-
vations of the cytoprotective properties of TTM in cardio-
myocytes, especially when initiated during the OGD phase
[9, 10].
This is especially interesting in the case of the antiapopto-
tic CIRBP, which has just recently been described as potential
DAMP when secreted to the extracellular matrix [40]. More-
over, CIRBP has been shown to increase serum levels of
TNF-α, IL-6, and HMGB-1 via activation of the TLR4-
MD2-complex when given to healthy rats [40, 41]. This
6 h
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Figure 5: RT-qPCR gene expression analysis of the cold-inducible RNA binding proteins (a) RBM3 and (b) CIRBP after exposure to 6 hours
OGD followed by 12 and 24 hours reperfusion (18 hours and 30 hours after experimental start, respectively) at 37°C and 33.5°C. Data from at
least 3 independent experiments are shown as mean ± SD. Statistical analysis was performed using one-way ANOVA with Tukey posttest;
#p < 0:05 as compared to 37°C normoxia control group and ∗p < 0:05 comparison between the two experimental groups were considered
significant.
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emphasizes the balancing act between induction of intracel-
lular protective proteins and prevention of their release into
the extracellular matrix via active or passive secretion mech-
anisms that can potentially result in damaging effects. In
order to augment the potential cardioprotective effects of
TTM and reduce the detrimental effects of the release of
DAMPs, which include initiation of a sterile inflammatory
response or worsening of clinical outcome as previously
described for CIRBP, the application of DAMP-neutralizing
antibodies or filters is conceivable. Godwin et al. showed sig-
nificantly increased survival rates (75% vs. 37.5%) and
reduced markers for hepatic damage when treated with a
CIRBP-neutralizing antibody after hepatic I/R injury [42].
5. Conclusion
Targeted temperature management initiated 1 hour after
exposure to OGD significantly increases murine primary car-
diomyocyte viability, as observed by significant reduction in
apoptotic caspase-3 activation and LDH release to the cul-
tured supernatant. Interestingly, the underlying cell death
mechanisms induced by exposure to OGD/R are dependent
on the duration of the inflicted cell injury and shift from apo-
ptosis to necrosis with increasing durations of OGD. Addi-
tionally, the release of DAMPs correlated with observed
necrotic cell death and can potentially be attenuated by
TTM. Our findings suggest that cardiomyocytes, although
not primarily immunocompetent cells, are still able to con-
tribute to the innate immune response occurring after AMI.
However, cardiomyocytes do not contribute to the inflam-
matory response by directly producing proinflammatory
cytokines. Therefore, the anti-inflammatory and cardiopro-
tective effect of TTM could possibly be augmented by target-
ing the attenuation of DAMP release. Further mechanisms of
cardioprotection initiated by TTM include the expression of
cold-shock proteins RBM3 and CIRBP in the late reperfusion
phase, indicating that the antiapoptotic effects of TTM are
lasting beyond the acute injury phase. Our findings suggest
that TTM is a promising therapeutic approach for cardiopro-
tection and, therefore, confirm the results of many previous
in vivo and in vitro studies. In order to further investigate
the effects of TTM, the experimental protocol needs to be
transferred to a coculture model including immunocompe-
tent cells of the myocardium, such as macrophages. Eventu-
ally, more clinical studies will be necessary to elaborate an
optimal time-temperature protocol for the induction of
TTM in patients after AMI.
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